Optimal immunosuppressive regimen for hepatitis B-positive kidney transplant recipients

Transplant Proc. 1996 Jun;28(3):1495-7.
No abstract available

MeSH terms

  • Actuarial Analysis
  • Adult
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Female
  • Graft Survival*
  • Hepatitis B / complications*
  • Hepatitis B / mortality
  • Hepatitis B Surface Antigens / blood*
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Survival Rate

Substances

  • Hepatitis B Surface Antigens
  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisone